Product analysis
Aminogex Ultra Miami Vice combines amino acids and minerals, with taurine offering a limited connection to running performance. Unnamed blends make the full contents harder to judge, and broader recovery benefits remain uncertain.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality27
Several mineral sources are named, but many amino acid preparations are unspecified. Unnamed blends further limit a complete quality comparison.
Ingredient Transparency59
The listed amounts are disclosed, helping compare servings. Unnamed blend components or undisclosed source proportions leave the full composition unclear.
Value For Money34
Betaine compares favourably on serving cost, while leucine offers a more moderate comparison. Several other amino acids compare poorly, and value for much of the mineral mix remains uncertain.
Customer Satisfaction64
Customer ratings are generally positive within a small review base. The feedback does not establish effectiveness or safety.
Product Focus15
The clearest fitness connection is a small, event-specific running benefit linked to taurine. The broad mix does not establish extra recovery benefits, and unnamed blends prevent a complete picture.
- Format
Powder - Container
- 516 Gram(s)
- Per serving
- $1.33
- Also available
Aminogex Ultra Watermelon- Customer rating
- 4.4 · 29 ratings
Goals
No linked studies yet.
No linked studies yet.
No linked studies yet.
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin B12 (Methylcobalamin) | 30 mcg | |
Calcium (Calcium Bisglycinate Chelate) | 9 mg | |
Magnesium (TRAACS Magnesium Bisglycinate Chelate, TRAACS Magnesium Glycinate Glutamine Chelate) | 38 mg | |
Chloride (Sodium Chloride) | 29 mg | |
Sodium (Sodium Chloride) | 20 mg | |
Potassium (Potassium Bisglycinate Chelate) | 9 mg | |
Instantized Vegan BCAAs | 7000 mg | |
L-Leucine | 3500 mg | |
L-Isoleucine | 1750 mg | |
L-Valine | 1750 mg | |
EAA Blend | 3000 mg | |
L-Lysine Hydrochloride | 1250 mg | |
L-Threonine | 1100 mg | |
L-Phenylalanine | 475 mg | |
L-Tryptophan | 75 mg | |
L-Histidine | 50 mg | |
L-Methionine | 50 mg | |
Endurance and Recovery Support | 2650 mg | |
Betaine Anhydrous | 1250 mg | |
L-Taurine | 1000 mg | |
Magnesium Glycinate Glutamine Chelate | 400 mg | |
Hydration Mineral Electrolyte Complex | 200 mg | |
Potassium Bisglycinate Chelate | 50 mg | |
Calcium Bisglycinate Chelate | 50 mg | |
Sodium Chloride | 50 mg | |
Magnesium Bisglycinate Chelate | 50 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Isomer Purity and Sourcing
Dose, Safety & Label Transparency100
Muscle Protein Synthesis (MPS) Dosage
Dosage Transparency
Value50
Price per Gram of Active Leucine
How this ingredient is rated
Active Ingredient Quality & Bioavailability71
Valine Isomer and Source Type
Third-Party Sport Certifications
Dose, Safety & Label Transparency100
Valine Dosage Efficacy
Label Transparency and Proprietary Blends
Value40
Price Per Gram of Valine
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Free-Form vs. Protein-Bound
Sourcing and Purity Signals
Dose, Safety & Label Transparency80
Isoleucine Potency per Serving
Label Transparency & Blend Disclosure
Third-Party Safety & Sport Testing
Value20
Price per Serving Efficiency
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.
- Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies.
- Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
- Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
- Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies.
- Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
- Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials.
- Twenty-Four-Hour Urinary Sodium and Potassium Excretion and Their Associations With Blood Pressure Among Adults in China: Baseline Survey of Action on Salt China.
- Dietary Sodium and Potassium Intake and Risk of Non-Fatal Cardiovascular Diseases: The Million Veteran Program.
- Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.
- Taurine ameliorates blood pressure and vascular function in patients with type 2 diabetes: Randomized, double-blind, placebo-controlled trial.
- Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
- Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials.
- The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
- Vitamin B12 Status and Cardiovascular Risk: Novel Insights from NMR-Based Lipoprotein Profiling in 20,665 Adults.
- Pregnancy Metal Mixtures and Blood Pressure and Hypertension in Mid-Life: A Prospective U.S. Cohort Study.
- Vitamin B12 Deficiency, Hyperhomocysteinemia, and Diabetes as Metabolic Determinants of Cardiovascular Risk in Mexican Women.
- Impact of serum vitamin (Vitamin D, Vitamin B12) and trace element (Fe, Zn, Cu) levels on major adverse cardiovascular events and poor prognosis in STEMI patients undergoing primary PCI.
- Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.